Article
The use of dual β-lactams to restore susceptibility of Mycobacterium avium complex
3 Sept 2024
Abstract excerpt
Abstract Background The Mycobacterium avium complex (MAC) are non-tuberculous mycobacteria responsible for chronic and debilitating conditions. Guideline-recommended therapy for MAC is a combination of clarithromycin/azithromycin, ethambutol and a rifamycin. However, culture conversion rates with this regimen are 67%. Alternative treatment options are needed. Recent findings of β-lactam combinations in the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
